Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MLX pseudogene 1 (MLXP1)
- Target
- MLXP1
- Molecular classification
- Other (Pseudogene)
01
Overview
MLX pseudogene 1 (MLXP1) represents a genomic locus classified as a pseudogene related to the MLX gene, which encodes Max-like protein X, a basic helix-loop-helix leucine zipper (bHLH-Zip) transcription factor involved in carbohydrate and lipid metabolism. However, as a pseudogene, MLXP1 does not produce a functional protein, and there are no known biological functions, molecular activities, or disease associations specific to MLXP1. It is not considered a therapeutic target, drug receptor, or biomarker, and it is likely included in reference databases for genome annotation or evolutionary studies rather than pharmacological or clinical relevance.
- Other names
- MLXP1
Beyond the preview
Go deeper on MLX pseudogene 1 (MLXP1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MLX pseudogene 1 (MLXP1).